Drug Shortage Report for IMITREX

Last updated on 2026-01-15

Report ID 271901
Drug Identification Number 02230420
Brand name IMITREX
Common or Proper name sumatriptan nasal spray
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) SUMATRIPTAN
Strength(s) 20MG
Dosage form(s) SPRAY
Route of administration NASAL NASAL
Packaging size 2s
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-12-05
Estimated end date 2026-01-13
Actual end date 2026-01-14
Shortage status Resolved
Updated date 2026-01-15
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2026-01-15 English Compare
v14 2026-01-14 French Compare
v13 2026-01-14 English Compare
v12 2026-01-14 French Compare
v11 2026-01-14 English Compare
v10 2026-01-08 French Compare
v9 2026-01-08 English Compare
v8 2025-12-06 English Compare
v7 2025-12-05 French Compare
v6 2025-12-05 English Compare
v5 2025-11-28 French Compare
v4 2025-11-28 English Compare
v3 2025-11-27 English Compare
v2 2025-11-14 French Compare
v1 2025-11-14 English Compare

Showing 1 to 15 of 15